Payel J. Roy, MD, is Assistant Professor of Medicine and Clinical Director of the Addiction Medicine Consult Service. Prior to moving to Pittsburgh, she completed two fellowships, the Boston University Addiction Medicine Fellowship Program and the Integrated Care for Addiction, HIV and HCV Research and Education Fellowship at the Boston University School of Public Health. Her research interests are centered on low-barrier access to addiction treatment and trainee education in addiction. Her current focus is a collaboration with the Allegheny County Health Department to develop the Bridge Clinic, including figuring out protocols. In the future, she’d like to expand her research into other areas related to opioid use disorders, such as safe injection facilities, harm reduction effort, and even other substance use disorders.
Dr. Roy is still exploring her new South Side neighborhood, but has already discovered the great burgers at Double Wide Grill. She’s loving the opportunity to get to know Pittsburgh—including trying out axe throwing—and experiencing local outdoor activities such as visiting Ohiopyle State Park, rock climbing, and hiking. You can follow her on Twitter @Payel_MD.
Education & Training
- BA (Biology), New York University, 2009
- MD (Medicine), Stony Brook University School of Medicine, 2013
- MSc (Health Services and Systems Research), Boston University School of Public Health, 2019
- Primary Care Training Program, Boston Medical Center, 2016
- Boston University Addiction Medicine Fellowship Program, Boston University School of Medicine Clinical Addiction Research and Education Unit, 2019
- Integrated Care for Addiction, HIV and HCV Research and Education Fellowship, Boston University School of Public Health, 2019
Roy PJ, Stein MD. Offering emergency buprenorphine without a prescription. Journal of the American Medical Association. 2019;322(6): 501-502.
Viewpoint discusses how allowing the sale of buprenorphine without a prescription in emergency circumstances could expand its use, and may benefit both individuals and the wider population.
Calcaterra SL, Bach P, Chadi A, Chadi N, Kimmel SD, Morford KL, Roy P, Samet JH. Methadone matters: what the United States can learn from the global effort to treat opioid addiction. Journal of General Internal Medicine. 2019.
This paper briefly reviews the evidence to support the use of medications to treat opioid use disorder with a specific focus on methadone.
Roy P, Jackson AH, Baxter J, Brett B, Winter M, Hardesty I, Alford DP. Utilizing a faculty development program to promote safer opioid prescribing for chronic pain in internal medicine resident practices. Pain Medicine. 2019.
This study implemented a skills-based faculty development program including a lecture followed by an Objective Structured Clinical Examination and found improvement in Internal Medicine faculty safe opioid prescribing knowledge, attitudes, and clinical and teaching confidence.
Merlin JS, Young SR, Starrels JL, Azari S, Edelman EJ, Pomeranz J, Roy P, Saini S, Becker WC, Liebshutz JM. Managing concerning behaviors in patients prescribed opioids for chronic pain: a Delphi study. Journal of General Internal Medicine. 2018; 33(2): 166-176.
In a clinical expert census about treatment approaches for patients on long-term opioid therapy, the most frequently cited common and challenging behaviors were missing appointments, taking opioids for symptoms other than pain, using more opioid medication than prescribed, asking for an increase in opioid dose, aggressive behavior, and alcohol and other substance use.
- Addiction medicine
- Opioid use disorder
- Low-barrier access to care